Analysts’ Viewpoint
The HbA1c laboratory testing market size is expected to witness steady growth in the near future due to increase in prevalence of diabetes and growth in awareness regarding glycemic control. Advancements in testing technologies and rise in geriatric population are likely to offer lucrative opportunities to vendors in the sector.
Most companies are vying for the HbA1c laboratory testing market share by offering innovative testing methodologies, automation, and improved accuracy. Regulatory changes and reimbursement policies are expected to significantly impact product pricing and market penetration of vendors.
Integration of Electronic Health Records (EHRs) and telehealth solutions is projected to spur the HbA1c laboratory testing market growth in the next few years. These developments are facilitating seamless data sharing between healthcare providers, laboratories, and patients, thereby enhancing the overall quality of care and enabling more personalized treatment approaches. High cost of testing devices and reagents and availability of alternative diabetes management tests are estimated to limit market progress to some extent.
HbA1c laboratory testing, also known as glycated hemoglobin testing, is a common diagnostic tool used in the management of diabetes mellitus. HbA1c stands for Hemoglobin A1c. It is a form of hemoglobin that is chemically linked to glucose (blood sugar) over time. The HbA1c test provides valuable information about a person's average blood sugar levels over approximately 2-3 months, which is the lifespan of a red blood cell.
Unlike traditional blood glucose monitoring, which offers a snapshot of glucose levels at a single point in time, HbA1c reflects glycemic control over an extended period. This allows for better treatment decisions and risk assessment for diabetes-related complications such as cardiovascular disease, retinopathy, and nephropathy.
HbA1c results help tailor treatment plans and assess the effectiveness of current therapies. It enables healthcare providers to make informed decisions regarding medication adjustments and lifestyle modifications. Maintaining a target HbA1c level can reduce the risk of diabetes-related complications. For individuals with diabetes, HbA1c testing offers insights into their overall health and empowers them to take control of their condition. By monitoring HbA1c levels regularly, they can make informed choices about diet, exercise, and medication adherence.
Increase in awareness regarding the importance of regular HbA1c testing for diabetes management, rise in advancements in testing technology, a surge in focus on preventive healthcare, and presence of favorable reimbursement policies and government initiatives to combat diabetes are major factors driving the demand for HbA1c testing.
Increase in prevalence of diabetes worldwide is significantly reshaping the healthcare landscape, particularly in terms of diagnostic testing. Among the pivotal tools in managing diabetes, the HbA1c laboratory test has emerged as a critical tool. Surge in demand for HbA1c tests is predominantly propelled by the escalating prevalence of diabetes, making it a cornerstone in disease management and prevention.
Diabetes has reached epidemic proportions, affecting millions across the world. According to the World Health Organization (WHO), the number of people with diabetes has quadrupled since 1980, with an estimated 422 million adults currently living with the condition. This alarming increase in cases has prompted healthcare systems to focus on early detection and monitoring of diabetes, placing HbA1c tests at the forefront.
According to International Diabetes Federation (IDF) data, the number of adults living with diabetes globally is projected to reach 643 million by 2030. This surge is driven by several factors, including population growth, aging, and urbanization. As per the Centers for Disease Control and Prevention (CDC), in 2022, an estimated 37.3 million people in the U.S. had diabetes, accounting for 11.3% of the population. Among them, 28.7 million people had diagnosed diabetes, and 8.5 million people had undiagnosed diabetes. The prevalence of diabetes has increased in the U.S. in the past few decades. In 2002, an estimated 8.3% of the population had diabetes, a figure that had increased to 11.3% by 2022.
HbA1c tests have gained popularity due to several advantages they offer. Unlike traditional blood glucose tests, HbA1c provides a long-term view of blood sugar control by averaging levels over three months. This provides a more comprehensive understanding of a patient's glycemic status, enabling healthcare providers to make informed decisions about treatment regimens. Furthermore, the convenience of HbA1c tests, which do not require fasting and can be carried out at any time of day, makes them more accessible and patient-friendly.
In the past few years, advancements in testing technology have revolutionized the field of healthcare diagnostics, particularly in the realm of diabetes management. One of the key beneficiaries of these technological leaps is the HbA1c laboratory testing business. Hemoglobin A1c testing plays a pivotal role in monitoring long-term blood sugar control in individuals with diabetes. The traditional method of measuring HbA1c involved time-consuming and cumbersome processes but the landscape is rapidly changing due to the integration of cutting-edge technologies.
Introduction of High Performance Liquid Chromatography (HPLC) and capillary electrophoresis methods is fueling the HbA1c laboratory testing market revenue. These technologies offer greater precision and speed in HbA1c measurements, enabling healthcare providers to make quicker and more accurate clinical decisions. Moreover, these techniques require smaller sample volumes, reducing patient discomfort, and the risk of complications associated with blood collection.
In 2023, the American Diabetes Association (ADA) and the American Association of Clinical Chemistry (AACC) released new guidance regarding the use of laboratory analysis in the diagnosis and management of diabetes. The ADA's guidance recommends HbA1c as the primary test employed for diagnosing diabetes and monitoring glycemic control. This is a significant change from previous guidance, which recommended using a combination of HbA1c and fasting plasma glucose testing.
Integration of data analytics and machine learning algorithms has enabled healthcare providers to extract valuable insights from HbA1c test results. This data-driven approach helps identify various diagnosis trends and predict future glycemic control, which is leading to more personalized and effective treatment strategies. It also facilitates remote monitoring, allowing healthcare professionals to remotely track patients' progress and intervene when necessary.
According to the latest HbA1c laboratory testing market trends, the ion exchange high performance liquid chromatography (HPLC) technology segment is projected to dominate the global sector during the forecast period. FDA approval for HPLC-based devices in the past few years, launch of new products, and increase in adoption of HbA1c testing in the diagnosis & monitoring of diabetes are boosting the segment.
HPLC is considered the gold standard method for HbA1c testing as it is highly accurate and precise. It is also very sensitive, which means that it can detect even small amounts of HbA1c in the blood. This is important for identifying patients with early-stage diabetes or prediabetes, as well as for monitoring patients with diabetes who are at risk of complications. A study published in the journal "Diabetes Research and Clinical Practice" found that HPLC was the most widely used method for HbA1c testing in Asia Pacific, accounting for over 70% of all tests performed.
According to the latest HbA1c laboratory testing market forecast, Asia Pacific is anticipated to hold largest share from 2023 to 2031. Increase in diabetes population in countries, such as India and China, is fueling the market dynamics of the region. According to the International Diabetes Federation, in 2021, China recorded about 141 million diabetic patients aged from 20 to 79 years, which was the highest number in any country. This figure is projected to reach 174 million by 2045.
Rise in prevalence of diabetes is augmenting the HbA1c laboratory testing market expansion during the forecast period. Diabetes management requires regular monitoring of blood glucose levels. HbA1c testing is a crucial tool for assessing long-term glycemic control.
There is a strong emphasis on diabetes management and prevention in North America, driven by public health initiatives, healthcare policies, and awareness campaigns. HbA1c testing plays a vital role in monitoring and managing diabetes, helping healthcare providers assess the effectiveness of treatment plans and make necessary adjustments. This focus on diabetes management contributes to the demand for HbA1c testing.
Surge in prevalence of diabetes, rise in adoption of advanced tools, and increase in disposable income are driving the HbA1c laboratory testing market trajectory in Europe. The region has one of the highest rates of diabetes in the world, with over 50 million people living with the condition. European laboratories are increasingly adopting advanced HbA1c testing technologies, which offer faster and more accurate results.
Major HbA1c laboratory testing companies are investing significantly in research & development and engaging in partnerships & agreements to expand their HbA1c Laboratory Testing Industry presence. Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, ARKRAY, Inc., EKF Diagnostics Holdings plc., and Meril Life Science Pvt. Ltd. are key entities operating in this industry.
The HbA1c laboratory testing market report profiles the top players based on various factors including company overview, financial summary, strategies, product portfolio, segments, and recent advancements.
| Attribute | Detail |
|---|---|
| Market Value in 2022 | US$ 5.8 Bn |
| Forecast Value in 2031 | More than US$ 9.5 Bn |
| Growth Rate (CAGR) | 5.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional-level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 5.8 Bn in 2022
It is projected to reach more than US$ 9.5 Bn by the end of 2031
It is anticipated to be 5.7% from 2023 to 2031
Rise in prevalence of diabetes and advancements in testing technologies
The ion exchange high performance liquid chromatography (HPLC) segment accounted for the largest share in 2022
Asia Pacific is expected to record the highest demand during the forecast period
Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, ARKRAY, Inc., EKF Diagnostics Holdings plc., and Meril Life Science Pvt. Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global HbA1c Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global HbA1c Laboratory Testing Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projection (US$ Bn)
5. Key Insights
5.1. Disease Prevalence and Incidence Rate
5.2. Regulatory Scenario
5.3. Quantitative Analysis of HbA1c Test in Laboratory and POC Settings, By Region
5.4. COVID-19 Pandemic Impact on Industry
6. Global HbA1c Laboratory Testing Market Analysis and Forecast, By Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Technology, 2017-2031
6.3.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
6.3.2. Immunoassay
6.3.3. Boronate Affinity Chromatography
6.3.4. Direct Enzymatic Assay
6.3.5. Others
6.4. Market Attractiveness By Technology
7. Global HbA1c Laboratory Testing Market Analysis and Forecast, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2017-2031
7.3.1. Diagnostic Laboratories
7.3.2. Hospital-based Laboratories
7.3.3. Others (Research Laboratories, etc.)
7.4. Market Attractiveness By End-user
8. Global HbA1c Laboratory Testing Market Analysis and Forecast, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America HbA1c Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Technology, 2017-2031
9.2.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
9.2.2. Immunoassay
9.2.3. Boronate Affinity Chromatography
9.2.4. Direct Enzymatic Assay
9.2.5. Others
9.3. Market Value Forecast By End-user, 2017-2031
9.3.1. Diagnostic Laboratories
9.3.2. Hospital-based Laboratories
9.3.3. Others (Research Laboratories, etc.)
9.4. Market Value Forecast By Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Technology
9.5.2. By End-user
9.5.3. By Country
10. Europe HbA1c Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Technology, 2017-2031
10.2.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
10.2.2. Immunoassay
10.2.3. Boronate Affinity Chromatography
10.2.4. Direct Enzymatic Assay
10.2.5. Others
10.3. Market Value Forecast By End-user, 2017-2031
10.3.1. Diagnostic Laboratories
10.3.2. Hospital-based Laboratories
10.3.3. Others (Research Laboratories, etc.)
10.4. Market Value Forecast By Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Technology
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific HbA1c Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Technology, 2017-2031
11.2.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
11.2.2. Immunoassay
11.2.3. Boronate Affinity Chromatography
11.2.4. Direct Enzymatic Assay
11.2.5. Others
11.3. Market Value Forecast By End-user, 2017-2031
11.3.1. Diagnostic Laboratories
11.3.2. Hospital-based Laboratories
11.3.3. Others (Research Laboratories, etc.)
11.4. Market Value Forecast By Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Technology
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America HbA1c Laboratory Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Technology, 2017-2031
12.2.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
12.2.2. Immunoassay
12.2.3. Boronate Affinity Chromatography
12.2.4. Direct Enzymatic Assay
12.2.5. Others
12.3. Market Value Forecast By End-user, 2017-2031
12.3.1. Diagnostic Laboratories
12.3.2. Hospital-based Laboratories
12.3.3. Others (Research Laboratories, etc.)
12.4. Market Value Forecast By Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa HbA1c Laboratory Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Technology, 2017-2031
13.2.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
13.2.2. Immunoassay
13.2.3. Boronate Affinity Chromatography
13.2.4. Direct Enzymatic Assay
13.2.5. Others
13.3. Market Value Forecast By End-user, 2017-2031
13.3.1. Diagnostic Laboratories
13.3.2. Hospital-based Laboratories
13.3.3. Others (Research Laboratories, etc.)
13.4. Market Value Forecast By Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Technology
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Global HbA1c Laboratory Testing Market Position Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Bio-Rad Laboratories, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. F. Hoffmann-La Roche Ltd.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Danaher Corporation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Siemens Healthcare GmbH
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Thermo Fisher Scientific, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Ortho Clinical Diagnostics
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. ARKRAY, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. EKF Diagnostics Holdings plc
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Meril Life Science Pvt. Ltd.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by Technology, 2017-2031
Table 02: Global HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by End-user, 2017-2031
Table 03: Global HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 04: North America HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by Technology, 2017-2031
Table 05: North America HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by End-user, 2017-2031
Table 06: North America HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Country, 2017-2031
Table 07: Europe HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by Technology, 2017-2031
Table 08: Europe HbA1c Laboratory Testing Market Size (US$ Bn) Forecast, by End-user, 2017-2031
Table 09: Europe HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Asia Pacific HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Technology, 2017-2031
Table 11: Asia Pacific HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 12: Asia Pacific HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 13: Latin America HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Technology, 2017-2031
Table 14: Latin America HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 15: Latin America HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Middle East & Africa HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Technology, 2017-2031
Table 17: Middle East & Africa HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 18: Middle East & Africa HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, 2017-2031
Figure 02: Global HbA1c Laboratory Testing Market Value Share, by Technology, 2022
Figure 03: Global HbA1c Laboratory Testing Market Value Share, by End-user, 2022
Figure 04: Global HbA1c Laboratory Testing Market Value Share, by Region, 2022
Figure 05: Global HbA1c Laboratory Testing Market Value Share Analysis, by Technology, 2022 and 2031
Figure 06: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Ion Exchange High Performance Liquid Chromatography (HPLC), 2017-2031
Figure 07: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Immunoassay, 2017-2031
Figure 08: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Boronate Affinity Chromatography, 2017-2031
Figure 09: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Direct Enzymatic Assay, 2017-2031
Figure 10: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Others, 2017-2031
Figure 11: Global HbA1c Laboratory Testing Market Attractiveness Analysis, by Technology, 2023-2031
Figure 12: Global HbA1c Laboratory Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 13: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Diagnostic Laboratories, 2017-2031
Figure 14: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Hospital-based Laboratories, 2017-2031
Figure 15: Global HbA1c Laboratory Testing Market Revenue (US$ Bn), by Others (Research Laboratories, etc.) , 2017-2031
Figure 16: Global HbA1c Laboratory Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 17: Global HbA1c Laboratory Testing Market Value Share Analysis, by Region, 2022 and 2031
Figure 18: North America HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, 2017-2031
Figure 19: North America HbA1c Laboratory Testing Market Value Share Analysis, by Technology, 2022 and 2031
Figure 20: North America HbA1c Laboratory Testing Market Attractiveness Analysis, by Technology, 2023-2031
Figure 21: North America HbA1c Laboratory Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 22: North America HbA1c Laboratory Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 23: North America HbA1c Laboratory Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 24: North America HbA1c Laboratory Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 25: Europe HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, 2017-2031
Figure 26: Europe HbA1c Laboratory Testing Market Value Share Analysis, by Technology, 2022 and 2031
Figure 27: Europe HbA1c Laboratory Testing Market Attractiveness Analysis, by Technology, 2023-2031
Figure 28: Europe HbA1c Laboratory Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: Europe HbA1c Laboratory Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 30: Europe HbA1c Laboratory Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 31: Europe HbA1c Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 32: Asia Pacific HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, 2017-2031
Figure 33: Asia Pacific HbA1c Laboratory Testing Market Value Share Analysis, by Technology, 2022 and 2031
Figure 34: Asia Pacific HbA1c Laboratory Testing Market Attractiveness Analysis, by Technology, 2023-2031
Figure 35: Asia Pacific HbA1c Laboratory Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 36: Asia Pacific HbA1c Laboratory Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 37: Asia Pacific HbA1c Laboratory Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 38: Asia Pacific HbA1c Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 39: Latin America HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, 2017-2031
Figure 40: Latin America HbA1c Laboratory Testing Market Value Share Analysis, by Technology, 2022 and 2031
Figure 41: Latin America HbA1c Laboratory Testing Market Attractiveness Analysis, by Technology, 2023-2031
Figure 42: Latin America HbA1c Laboratory Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 43: Latin America HbA1c Laboratory Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 44: Latin America HbA1c Laboratory Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Latin America HbA1c Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 46: Middle East & Africa HbA1c Laboratory Testing Market Value (US$ Bn) Forecast, 2017-2031
Figure 47: Middle East & Africa HbA1c Laboratory Testing Market Value Share Analysis, by Technology, 2022 and 2031
Figure 48: Middle East & Africa HbA1c Laboratory Testing Market Attractiveness Analysis, by Technology, 2023-2031
Figure 49: Middle East & Africa HbA1c Laboratory Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 50: Middle East & Africa HbA1c Laboratory Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 51: Middle East & Africa HbA1c Laboratory Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Middle East & Africa HbA1c Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
HbA1c Laboratory Testing Market
